SCHEMBL28517437

SCHEMBL28517437

C=C1CCC(C)(C)c2cc(C)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 2/20 0.42
PGR P06401 1/20 0.36
CYP3A4 P08684 2/20 0.33
ALDH1A1 P00352 2/20 0.33
PDK2 Q15119 2/20 0.33
CYP1A2 P05177 1/20 0.32
POLB P06746 1/20 0.32
CYP2C19 P33261 1/20 0.32
PARP10 Q53GL7 2/20 0.31
PARP11 Q9NR21 1/20 0.31
PARP1 P09874 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA4 P22748 1/20 0.31
CA7 P43166 1/20 0.31
CA9 Q16790 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31106550 1.00 METAP1 (0.42) METAP1PGRCYP3A4ALDH1A1PDK2
SCHEMBL24055009 0.81 HTR2A (0.41) METAP1PGRPDK2
SCHEMBL31106549 0.81 HTR2A (0.41) METAP1PGRPDK2
SCHEMBL5648628 0.79 PGR (0.49) METAP1PGRCYP3A4ALDH1A1CYP1A2
SCHEMBL30695369 0.75 CYP3A4 (0.41) CYP3A4ALDH1A1CYP1A2POLBCYP2C19
SCHEMBL9770689 0.75 CYP3A4 (0.41) CYP3A4ALDH1A1CYP1A2POLBCYP2C19
SCHEMBL24369477 0.71 PGR (0.31) PGRCYP3A4CYP1A2POLBCYP2C19
SCHEMBL1615553 0.70 RXRA (0.46) CYP3A4ALDH1A1CYP1A2CYP2C19MEN1
SCHEMBL29606831 0.70 RXRA (0.46) CYP3A4ALDH1A1CYP1A2CYP2C19MEN1
SCHEMBL5763435 0.69 CYP3A4 (0.50) METAP1CYP3A4ALDH1A1PARP10PARP11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112218629-A Bexarotene derivatives and their use in the treatment of cancer DJ疗法有限责任公司 2021-01-12 CN disclosed